|
|
||||||||
Journal of Applied Physiology, Vol 71, Issue 3 807-814, Copyright © 1991 by American Physiological Society
ARTICLES |
H. Jin, R. H. Yang, Y. F. Chen, R. M. Jackson, H. Itoh, M. Mukoyama, K. Nakao, H. Imura and S. Oparil
Department of Medicine, University of Alabama, Birmingham 35294.
To test the hypothesis that exogenous atrial natriuretic peptide (ANP) prevents the acute pulmonary pressor response to hypoxia, ANP (20-micrograms/kg bolus followed by 1-microgram.kg-1.min-1 infusion) or vehicle was administered intravenously to conscious rats beginning 3 min before exposure to hypoxia or room air for 90 min. Exogenous ANP abolished the acute pulmonary pressor response to hypoxia in association with marked and parallel increases in plasma ANP and guanosine 5'-cyclic monophosphate (cGMP) and with a significant increase in lung cGMP content. To examine whether endogenous ANP modulates the acute pulmonary pressor response to hypoxia, rats were pretreated with a monoclonal antibody (Ab) to ANP and exposed to hypoxia. Mean pulmonary arterial pressure (MPAP) in the Ab-treated rats was not different from control over the first 6 h of hypoxic exposure. Thereafter, the Ab-treated group had significantly higher MPAP than control. Our data suggest that 1) exogenous ANP blocks the pulmonary pressor response to acute hypoxia via stimulation of cGMP accumulation in the pulmonary vasculature, and 2) endogenous ANP may modulate the subacute, but not acute, phase of hypoxic pulmonary hypertension.
This article has been cited by other articles:
![]() |
J. R. Klinger, L. Pietras, R. Warburton, and N. S. Hill Reduced Oxygen Tension Increases Atrial Natriuretic Peptide Release from Atrial Cardiocytes Experimental Biology and Medicine, October 1, 2001; 226(9): 847 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Sun, S. Oparil, P. Lucchesi, J. A. Thompson, and Y.-F. Chen Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L155 - L163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Sun, S.-J. Chen, G. Li, and Y.-F. Chen Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L511 - L519. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Klinger, R. R. Warburton, L. A. Pietras, O. Smithies, R. Swift, and N. S. Hill Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L868 - L874. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Klinger, F. M. Siddiq, R. A. Swift, C. Jackson, L. Pietras, R. R. Warburton, C. Alia, and N. S. Hill C-type natriuretic peptide expression and pulmonary vasodilation in hypoxia-adapted rats Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L645 - L652. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. E. Albert, V. L. Tucker, and E. M. Renkin Atrial natriuretic peptide levels and plasma volume contraction in acute alveolar hypoxia J Appl Physiol, January 1, 1997; 82(1): 102 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. E. Albert, V. L. Tucker, and E. M. Renkin Acute alveolar hypoxia increases blood-to-tissue albumin transport: role of atrial natriuretic peptide J Appl Physiol, January 1, 1997; 82(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Chen, J. Durand, and W. C. Claycomb Hypoxia Stimulates Atrial Natriuretic Peptide Gene Expression in Cultured Atrial Cardiocytes Hypertension, January 1, 1997; 29(1): 75 - 82. [Abstract] [Full Text] |
||||
![]() |
S.-T. Zhu, Y.-F. Chen, J. M. Wyss, K. Nakao, H. Imura, S. Oparil, and D. A. Calhoun Atrial Natriuretic Peptide Blunts Arterial Baroreflex in Spontaneously Hypertensive Rats Hypertension, February 1, 1996; 27(2): 297 - 302. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |